NEW YORK, March 19 – Genomics One of Laval, Quebec and Alpha Helix of Uppsala, Sweden have developed a new PCR cloning kit, the companies said Monday.
Genomics One will have exclusive marketing rights for the cloning kits, which combine Alpha Helix’s MicroCartridge liquid dispensing technology and Genomics One’s True Blue cloning technology. Genomics One will pay Alpha Helix for the raw materials used for the kits, but does not have to pay additional sums for the marketing rights.
The kit is designed to save time and reagent costs, according to Genomics One. Users add their PCR products, insert the Microcartridge, which includes PCR reagents in its chambers, centrifuge, incubate the products at room temperature for five minutes, then transform the host cells.
"This new kit moves cloning and liquid handling to a whole new level and is uniquely positioned to meet the next challenges of the genomics sector," Suzanne Lebel, president of Genomics One, said in a statement.
Genomics One, founded in 1995, also offers a series of BAC and phage cloning vectors, and is developing engineered lyticase to use in glycotherapeutics manufacturing and as antifungal agent, and TAG/Anchor technology for gene expression and diagnostic applications.
The company is also working on sequencing gaps in the human genome, the rice genome, the whooping cough agent, Bordetella pertussis , the Staphylococcus aureus genome, and the Influenza virus genome.